These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34276212)

  • 1. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
    Tan R; Tian D; Liu J; Wang C; Wan Y
    Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
    Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
    Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
    Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
    Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
    Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
    J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.
    Hu H; Li Y; Zhou Q; Ao Y; Yu C; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30833-30844. PubMed ID: 27791359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
    Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin.
    Huan M; Zhang B; Teng Z; Cui H; Wang J; Liu X; Xia H; Zhou S; Mei Q
    PLoS One; 2012; 7(9):e44116. PubMed ID: 23028490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 11. Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC.
    Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Zhang Z; Pang X; Zhu C
    Int J Nanomedicine; 2020; 15():6153-6165. PubMed ID: 32884269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of sialic acid to the enhanced tumor targeting efficiency of nanoparticles engineered with doxorubicin.
    Lee SY; Nam S; Koo JS; Kim S; Yang M; Jeong DI; Hwang C; Park J; Cho HJ
    Sci Rep; 2020 Nov; 10(1):19738. PubMed ID: 33184416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
    J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diselenide-triggered hydroxyethyl starch conjugate nanoparticles with cascade drug release properties for potentiating chemo-photodynamic therapy.
    Tan R; Ge J; Wang C; Wan Y; Yang X
    Carbohydr Polym; 2023 Jul; 311():120748. PubMed ID: 37028875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin.
    Nguyen CT; Tran TH; Amiji M; Lu X; Kasi RM
    Nanomedicine; 2015 Nov; 11(8):2071-82. PubMed ID: 26169153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
    Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
    Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.